NCOA3 and colorectal carcinoma: Consistent with our findings, knockdown of NCOA3 decreased cell proliferation, colony formation, and tumorigenesis of CRC cells in vitro and in vivo (Mo et al., 2015), suggested that MAD2L2 was a novel regulator of NCOA3 in CRC progression.